Ranbaxy Ban
- All
- News
- Videos
-
India Acts to Repair Reputation as Drugs Exporter
India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Flies in Ranbaxy's sample storage room in Punjab plant, says FDA report
US health regulator Food and Drug Administration has found as many as eight lapses in Ranbaxy's Toansa plant in Punjab which was recently banned by the US drug inspectors from making products for the American market.
-
US FDA bans more products from Ranbaxy
The U.S. Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Ltd from entering the United States due to manufacturing violations.
-
India Acts to Repair Reputation as Drugs Exporter
India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Flies in Ranbaxy's sample storage room in Punjab plant, says FDA report
US health regulator Food and Drug Administration has found as many as eight lapses in Ranbaxy's Toansa plant in Punjab which was recently banned by the US drug inspectors from making products for the American market.
-
US FDA bans more products from Ranbaxy
The U.S. Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Ltd from entering the United States due to manufacturing violations.
